|Age:||18 to 50 years old|
|Keywords:||Osteosarcoma, fertility, fertility after chemotherapy, male fertility, male fertility after chemotherapy, male fertility after osteosarcoma|
The study team will make sure you qualify to take part in the study. Qualified participants will receive detailed information about the study. This may include a list of study-related tests and procedures.
Age: Patients must be ≥ 18 and ≤ 50 years of age at the time of enrollment
Previous Enrollment: Previously enrolled and randomized on AOST0331 or CCG7921 (also known as INT0133 and POG9351)
Diagnosis: Osteosarcoma survivors without relapse or a subsequent malignancy other than skin cancer following initial treatment on AOST0331 or CCG7921 (also known as INT0133 and POG9351)
Language: Able to speak, read and write in English or Spanish
Regulatory Requirements All patients and/or their parents or legal guardians must sign a written informed consent.
All institutional, FDA, and NCI requirements for human studies must be met.
Have any questions or want to learn more? Leave your contact details below and the research team will reach out to you.